Position of Design & Copyright Protection in Pharmaceutical Industry

Q: What is law available for the protection of graphics, contents, visual elements & creativity available on the packing material and novel appearance of the pharma related products.
– Ashok Kumar
A: Except so many other factors, the pharma products are known with their brands and style of packing material. The exclusive, unique & creative designs of the products their containers and packing material play an important role in the recognition of the products which do not only keep the products in a different track from others but contribute to the goodwill of the brands and company also. For such kind of arrangements, the design of the products should be different from others and should be protected by the design registration. Here, the Industrial Design refers to the “Design” defined under the “Design Act, 2000” which is further registered under the same Act. As per the provision of this Act, “design” means only the features of shape, configuration, pattern, ornament or composition of lines or colors applied to any article whether in two dimensional or three dimensional or in both forms, by any industrial process or means, whether manual, mechanical or chemical, separate or combined, which in the finished article appeal to and are judged solely by the eye. The design of any pharma product to be registrable under the act should be new and original.

The copyright protection also has its place in pharma sector in the same way as design does through the protection of graphics, contents, visual elements, text material & creativity available on the packing material of the pharma products. Protecting through copyright registration, one can keep his packing material, outer carton’s design and appearance of pharma related products safe from being infringed which results from unauthorized use, copy or duplication.

Dr. Javed Hasan,
Advocate (High Court, Delhi) Through,
Lex Intellectia Attorneys for, Drugs & IPR Laws
Email : lexintellectia@gmail.com
Phone : 9818522970

Related Posts

  • Pharma
  • April 3, 2025
  • 96 views
Nifty Pharma soars 3% on exclusion from Trump’s reciprocal tariffs; Sun Pharma, IPCA Labs up 5%

Domestic pharmaceutical players heaved a sigh of relief in trade on April 3, while the other sectors see intense selling pressure, as the White House has excluded pharmaceuticals products from…

  • Pharma
  • April 3, 2025
  • 117 views
Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

US President Donald Trump has exempted pharmaceuticals from his reciprocal tariff plan announced on April 3. While he imposed a 26% tariff on other imports from India, this exemption has…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Is Gujarat’s Health Department Rebelling against PM Modi Government?

Is Gujarat’s Health Department Rebelling against PM Modi Government?

Nifty Pharma soars 3% on exclusion from Trump’s reciprocal tariffs; Sun Pharma, IPCA Labs up 5%

Nifty Pharma soars 3% on exclusion from Trump’s reciprocal tariffs; Sun Pharma, IPCA Labs up 5%

Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

Fake pharmacy registration racket busted in Delhi, 47 held

Fake pharmacy registration racket busted in Delhi, 47 held